Table 12.8

Adjusted Graft Survival, Deceased Donor Lung Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

  3 Months 1 Year 3 Years 5 Years
(Tx 2003 - 2004) (Tx 2003 - 2004) (Tx 2001 - 2004) (Tx 1999 - 2004)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 2,218 92.7% 0.6% 2,218 83.8% 0.8% 4,280 64.5% 0.9% 6,083 48.3% 0.9%
Primary Diagnosis Emphysema/COPD 852 94.7% 0.8% 852 87.2% 1.2% 1,729 67.7% 1.5% 2,519 49.4% 1.6%
Cystic Fibrosis 367 93.8% 1.4% 367 83.0% 2.5% 680 66.2% 2.6% 980 47.0% 2.7%
Idiopathic Pulmonary Fibrosis 514 89.8% 1.4% 514 79.2% 1.9% 893 59.1% 2.1% 1,178 45.8% 2.2%
Alpha-1-Antitrypsin Deficiency 126 92.6% 2.4% 126 89.2% 2.8% 290 66.7% 3.3% 428 50.6% 3.6%
Primary Pulmonary Hypertension 79 81.8% 4.5% 79 74.5% 5.2% 166 60.6% 4.3% 243 50.2% 4.3%
Congenital Disease 18 100.0% 0.0% 18 88.8% 7.3% 36 52.8% 10.8% 64 47.8% 7.7%
Other 238 92.2% 1.8% 238 78.7% 2.8% 460 61.9% 2.8% 641 53.9% 2.6%
Unknown 24 79.1% 8.1% 24 70.8% 9.1% 26 69.4% 8.8% 30 52.2% 14.8%


Source: OPTN/SRTR Data as of May 1, 2006.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Graft survival follows individual transplants until graft failure. Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on lung and heart-lung transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.